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Abstract: Store-operated heteromeric Orai1/Orai3 channels have been discussed in the context of
aging, cancer, and immune cell differentiation. In contrast to homomeric Orai1 channels, they exhibit a
different pharmacology upon application of reactive oxygen species (ROS) or 2-aminoethoxydiphenyl
borate (2-APB) in various cell types. In endogenous cells, subunit composition and arrangement
may vary and cannot be defined precisely. In this study, we used patch-clamp electrophysiology
to investigate the 2-APB profile of store-operated and store-independent homomeric Orai1 and
heteromeric Orai1/Orai3 concatenated channels with defined subunit compositions. As has been
shown previous, one or more Orai3 subunit(s) within the channel result(s) in decreased Ca2+ release
activated Ca2+ current (ICRAC). Upon application of 50 µM 2-APB, channels with two or more
Orai3 subunits exhibit large outward currents and can be activated by 2-APB independent from
storedepletion and/or the presence of STIM1. The number and position of Orai3 subunits within the
heteromeric store-operated channel change ion conductivity of 2-APB-activated outward current.
Compared to homomeric Orai1 channels, one Orai3 subunit within the channel does not alter 2-APB
pharmacology. None of the concatenated channel constructs were able to exactly simulate the complex
2-APB pharmacology observed in prostate cancer cells. However, 2-APB profiles of prostate cancer
cells are similar to those of concatenated channels with Orai3 subunit(s). Considering the presented
and previous results, this indicates that distinct subtypes of heteromeric SOCE channels may be
selectively activated or blocked. In the future, targeting distinct heteromeric SOCE channel subtypes
may be the key to tailored SOCE-based therapies.
Keywords: Orai1; Orai3; concatenated channels; ICRAC; SOCE; 2-APB
1. Introduction
In the last 14 years, many different groups advanced the understanding of structure–function
relationships of store-operated Ca2+ entry (SOCE) channels. Numerous extracellular stimuli produce
intracellular second messenger inositol 1,4,5-trisphosphate (IP3) that subsequently releases Ca2+ via
IP3 receptors from intracellular Ca2+ stores, i.e., the endoplasmic reticulum (ER). Upon ER depletion,
Ca2+ dissociates from stromal interaction molecule 1′s (STIM1) EF hand motif in the ER lumen.
Consequently, STIM1 cluster in the ER membrane recruit and activate Orai1 channels in the plasma
membrane. Studies in the past proposed a tetramer of Orai1 proteins to form a functional SOCE
channel [1–4]. Later on, functional and structural studies suggested hexameric Orai1 channels [5–7].
In endogenous cells, large Orai1 channel complexes have been observed in liquid-phase scanning
transmission electron microscopy and in native gels that may have been of tetrameric or hexameric
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origin [8]. The number of STIM1 molecules per Orai1 subunit varies and allows for a graded activation
of SOCE with an optimal STIM1:Orai1 ratio of 2:1 [9–12].
Apart from Orai1, Orai2 and Orai3 isoforms are expressed throughout various tissues [13].
In addition to forming homomeric Orai1 SOCE channels, Orai1 proteins multimerize with Orai family
members Orai2 and Orai3 when overexpressed [14]. Endogenous heteromeric SOCE channels have
been reported in different cell types [15–22]. Orai3 may be a negative modulator as, upon knockdown
of Orai3, SOCE can be increased [15–18,23,24]. In contrast, in other studies, SOCE is decreased
upon knockout of Orai3, indicating a role as a positive modulator of SOCE [25–28]. In addition,
heteromeric Orai1/Orai3 channels can be activated store-independently [29–31] and/or form arachidonic
acid-activated pentameric channels [32,33]. Finally, Orai3 has also been reported to form ER Ca2+
leakage channels [34]. Many pathophysiological cellular functions in aging and cancer involve
SOCE and Orai3 [26,27,35–40], highlighting the importance of understanding the pharmacology of
Orai1/Orai3 heteromeric SOCE channels.
A widely used tool compound to investigate SOCE and the underlying Ca2+ release activated
Ca2+ current (ICRAC) is 2-aminoethoxydiphenyl borate (2-APB). Upon application of 2-APB, ICRAC is
first amplified and then blocked in different cell types, including T cells, B cells and mast cells [41–43].
One hallmark of the STIM1/Orai1-mediated ICRAC is its bimodal action upon application of 50 µM
2-APB: ICRAC is first amplified and then blocked [44]. The 2-APB response depends on the STIM1/Orai1
ratio [45]. The gathered data suggest that 2-APB’s action is directed toward the STIM1-Orai1 coupling
interface [46] and ICRAC amplification is due to Orai1 pore dilation [47] and/or enhancement of STIM1/Orai1
coupling [48]. ICRAC mediated by STIM1/Orai2 and STIM1/Orai3 channels differs in its response upon
application of 50 µM 2-APB. In STIM1/Orai2 cells, 50 µM 2-APB first amplifies and then blocks ICRAC
by ~ 50% whereas ICRAC mediated by STIM1/Orai3 is not blocked but amplified [14]. In addition, upon
the application of 2-APB, STIM1/Orai3-mediated ICRAC develops a large outward current and can be
activated by 2-APB without STIM1 [49–51], presumably due to a widening of the pore [52].
First structural insights regarding the differences between Orai1 and Orai3-containing channels
was reported by Zhang et al. Using various chimeric Orai1/Orai3 constructs, they demonstrated that
the segment between the second and third transmembrane domain is responsible for 2-APB-induced
Orai3 currents [51]. Later on, residues C101 and G158 within this sequence were proposed to be close
to the 2-APB-sensitive site [53] and the 2-APB-induced pore is formed by TM1 residues and E165 in
TM3 [54]. Furthermore, the N-terminus of Orai3 was suggested to be involved in 2-APB-dependent
gating of Orai3 [55]. Conferring the N-terminus of Orai3 to Orai1 also decreased affinity for scaffold
protein AKAP79 [56]. It has been proposed that before 2-APB is able to gate Orai3, STIM1 has to
dissociate from the channel complex first [57]. Experiments with Orai1-Orai3 tandem constructs
demonstrated that heteromeric store-operated Orai1/Orai3 channels exhibit a reduced Ca2+ selectivity
and a pharmacological profile that differs from homomeric Orai1 or Orai3 channels [58].
The 2-APB-induced response in endogenous systems varies with Orai1 and Orai3 expression
levels [18,25,27,28,40,59]. Tetrameric concatenated Orai channels have been shown to mediate ICRAC
in the past [33]. For instance, these channel constructs have been used to demonstrate that one
Orai3 subunit within heterotetrameric concatenated Orai1/Orai3 channels confers insensitivity against
reactive oxygen species (ROS) to ICRAC [15]. Deciphering the multiplex pharmacological profile of
heteromeric CRAC channels could be the key towards targeting specific CRAC channel subtypes in
diseases. With this in mind, we investigated 2-APB pharmacology of tetrameric concatenated Orai1
and Orai1/Orai3 channels.
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2. Results
2.1. Store-Operated Orai1, Orai3 and Concatenated Orai1/Orai3 Channels
We transfected HEK293 cells stably expressing STIM1 (HEK STIM1) with Orai1 (Figure 1A) or Orai3
(Figure 1B) and evoked ICRAC with 50 µM IP3 and 20 mM BAPTA in the patch pipette. Whole cell currents
were extracted at -130 mV and +130 mV and plotted versus time. Upon ICRAC development, we applied
50 µM 2-APB from 120–180 s. Under these conditions STIM1/Orai1-mediated ICRAC is first amplified and
then blocked, while STIM1/Orai3-mediated ICRAC (CD at t = 116 s ~11 pA/pF) was amplified and a large
outward current developed. Current–voltage relationships (IV) at the indicated time points are shown as
insets (Figure 1A,B). These findings are in line with previously published results [50,60].
In order to investigate the 2-APB-induced pharmacological profile of heteromeric Orai1/Orai3
CRAC channels, we transfected HEK STIM1 with Orai1 and Orai3 with a ratio of 4:1, assuming that in
most cells Orai1 is the predominant endogenously expressed family member. We evoked ICRAC and
applied 50 µM 2-APB as described above and CD was plotted versus time (Figure 1C). IVs extracted at
the indicated time points are shown as inset (Figure 1C). Under these conditions, Orai1/Orai3-mediated
ICRAC is reduced compared to Orai1-mediated currents. Upon application of 2-APB, the average
CD via Orai1/Orai3 (Figure 1C) is reduced to a lesser extent than Orai1 (Figure 1A) and an outward
current developed that was lower when compared to Orai3-mediated currents (Figure 1B). Using our
experimental conditions, cellular responses varied as cells expressed different ratios of Orai1/Orai3
subunits and within one cell, channels may have been assembled in varying ratios (light grey traces in
Figure 1C). We next transfected a construct expressing a concatenated Orai1/Orai3 channel composed of
one Orai3 and three Orai1 subunits (3-1-1-1) to investigate channels with a defined subunit composition
and arrangement (Figure 1D, single cell responses light grey traces). Under these conditions, a reduced
ICRAC and no outward current developed. The IVs are shown as inset in Figure 1D. Analysis of
IP3-induced inward currents and inward currents when 2-APB was applied extracted from single cells
from Figure 1C,D is shown in Figure 1E. Both parameters display a higher variance when channels
were transfected with Orai1 and Orai3 using a ratio of 4:1, compared to responses given by cells
transfected with the concatenated channel (3-1-1-1). Figure 1F compares outward CD from both systems.
Whilst variation of outward CD before 2-APB application is similar, outward currents of Orai1/Orai3
transfected cells show a larger scattering (s = 44.2) compared to 3-1-1-1 (s = 1.3) transfected cells.
Given the variance of responses in Orai1:Orai3 (4:1) transfected cells, we assessed the
pharmacological profile of 2-APB in several store-operated concatenated channel constructs (1-1-1-1,
3-1-1-1, 3-1-1-3, 3-1-3-1, 3-1-3-3) (Figure 2A). Cells expressing concatenated Orai channels display a
significantly larger IP3-induced current compared to control transfected cells, demonstrating that
store release can activate all concatenated channels (Figure 2B). In addition, all concatenated Orai
channels expressing one or more Orai3 subunits display a significantly reduced IP3-induced current
when compared to homomeric Orai1 concatenated channels (Figure 2B). These findings are in line with
previous reports [15,33]. Upon application of 2-APB, concatenated channels with two or more Orai3
channels developed an outward current that increased with the number of Orai3 subunits within the
construct (Figure 2C). The arrangement of Orai1 and Orai3 in the channel apparently plays a role as
3-1-3-1 displays a significantly larger outward current component than 3-1-1-3. IVs extracted at the
indicated time points from cells expressing constructs 1-1-1-1, 3-1-1-1, 3-1-1-3, 3-1-3-1, 3-1-3-3 or cells
that were control transfected are shown in Figure 2D.
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Figure 1. 2-APB-mediated current density (CD) responses in HEK cells stably overexpressing STIM1 
with 50 µM IP3 and 0 nM Ca2+ in the patch pipette. (A) CD development over time with Orai1 
overexpression (n = 8) and application of 50 µM 2-APB as indicated. Inset: corresponding IV 
relationship. (B) Same experimental setting as in (A) but with Orai3 overexpression (n = 10). (C) Same 
experiment as in (A) but with overexpression of Orai1 and Orai3 in a ratio of 4:1 (n = 12) or (D) with 
overexpression of concatenated tetrameric channel 3-1-1-1 (n = 12), insets: corresponding IV 
relationship. The light grey traces are single cell recordings. A calculated CD taken from experiments 
in (A) and (B) is represented as a dark brown line in (C) (4 × CD from Orai1 + 1 × CD from Orai3 
divided by 5). (E) Extracted inward current densities from (C) + (D) at t = 116 s and t = 178 s. Single 
data points and mean values ± SD are shown. In addition, SD is stated as s. (F) same as in (E) but with 
extracted outward currents at the same time points. 
Figure 1. 2-APB-mediated current density (CD) responses in HEK cells stably overexpressing STIM1
with 50 µM IP3 and 0 nM Ca2+ in the patch pipette. (A) CD development over time with Orai1
overexpression (n = 8) and application of 50 µM 2-APB as indicated. Inset: corresponding IV
relationship. (B) Same experimental setting as in (A) but with Orai3 overexpression (n = 10). (C) Same
experiment as in (A) but with overexpression of Orai1 and Orai3 in a ratio of 4:1 (n = 12) or (D)
with overexpression of concatenated tetrameric channel 3-1-1-1 (n = 12), insets: corresponding IV
relationship. The light grey traces are single cell recordings. A calculated CD taken from experiments in
(A) and (B) is represented as a dark brown line in (C) (4 × CD from Orai1 + 1 × CD from Orai3 divided
by 5). (E) Extracted inward current densities from (C) + (D) at t = 116 s and t = 178 s. Single data points
and mean values ± SD are shown. In addition, SD is stated as s. (F) same as in (E) but with extracted
outward currents at the same time points.
Int. J. Mol. Sci. 2020, 21, 2458 5 of 13
 4 of 13 
 
In order to investigate the 2-APB-induced pharmacological profile of heteromeric Orai1/Orai3 
CRAC channels, we transfected HEK STIM1 with Orai1 and Orai3 with a ratio of 4:1, assuming that 
in most cells Orai1 is the predominant endogenously expressed family member. We evoked ICRAC and 
applied 50 µM 2-APB as described above and CD was plotted versus time (Figure 1C). IVs extracted 
at the indicated time points are shown as inset (Figure 1C). Under these conditions, Orai1/Orai3-
mediated ICRAC is reduced compared to Orai1-mediated currents. Upon application of 2-APB, the 
average CD via Orai1/Orai3 (Figure 1C) is reduced to a lesser extent than Orai1 (Figure 1A) and an 
outward current developed that was lower when compared to Orai3-mediated currents (Figure 1B). 
Using our experimental conditions, cellular responses varied as cells expressed different ratios of 
Orai1/Orai3 subunits and within one cell, channels may have been assembled in varying ratios (light 
grey traces in Figure 1C). We next transfected a construct expressing a concatenated Orai1/Orai3 
channel composed of one Orai3 and three Orai1 subunits (3-1-1-1) to investigate channels with a 
defined subunit composition and arrangement (Figure 1D, single cell responses light grey traces). 
Under these conditions, a reduced ICRAC and no outward current developed. The IVs are shown as 
inset in Figure 1D. Analysis of IP3-induced inward currents and inward currents when 2-APB was 
applied extracted from single cells from Figure 1C,D is shown in Figure 1E. Both parameters display 
a higher variance when channels were transfected with Orai1 and Orai3 using a ratio of 4:1, compared 
to responses given by cells transfected with the concatenated channel (3-1-1-1). Figure 1F compares 
outward CD from both systems. Whilst variation of outward CD before 2-APB application is similar, 
outward currents of Orai1/Orai3 transfected cells show a larger scattering (s = 44.2) compared to 3-1-
1-1 (s = 1.3) transfected cells. 
Given the variance of responses in Orai1:Orai3 (4:1) transfected cells, we assessed the 
pharmacological profile of 2-APB in several store-operated concatenated channel constructs (1-1-1-1, 
3-1-1-1, 3-1-1-3, 3-1-3-1, 3-1-3-3) (Figure 2A). Cells expressing concatenated Orai channels display a 
significantly larger IP3-induced current compared to control transfected cells, demonstrating that 
store release can activate all concatenated channels (Figure 2B). In addition, all concatenated Orai 
channels expressing one or more Orai3 subunits display a significantly reduced IP3-induced current 
when compared to homomeric Orai1 concatenated channels (Figure 2B). These findings are in line 
with previous reports [15,33]. Upon application of 2-APB, concatenated channels with two or more 
Orai3 channels developed an outward current that increased with the number of Orai3 subunits 
within the construct (Figure 2C). The arrangement of Orai1 and Orai3 in the channel apparently plays 
a role as 3-1-3-1 displays a significantly larger outward current component than 3-1-1-3. IVs extracted 
at the indicated time points from cells expressing constructs 1-1-1-1, 3-1-1-1, 3-1-1-3, 3-1-3-1, 3-1-3-3 
or cells that were control transfected are shown in Figure 2D. 
 
Figure 2. Current density responses in HEK cells stably overexpressing STIM1 with overexpression of
concatenated tetrameric Orai1/Orai3 channels or empty vector control under store-depleting conditions.
(A) CD development over time and application of 50 µM 2-APB as indicated (1-1-1-1, n = 6; 3-1-1-1,
n = 12; 3-1-1-3, n = 10; 3-1-3-1, n = 7; 3-1-3-3, n = 10; control, n = 7). (B) Inward currents at t = 116 s
extracted from (A). (C) Outward currents extracted at t = 178 s extracted from (A). (D) Corresponding
IV relationships from (A). Statistical significance was determined by an unpaired t test with Welch’s
correction and is presented as ns p > 0.05, * p < 0.05, ** p < 0.005, *** p < 0.001, **** p < 0.0001.
2.2. Non-Store-Operated Orai1, Orai3 and Concatenated Orai1/Orai3 Channels
We next investigated the pharmacological profile upon application of 50 µM 2-APB when HEK
STIM1 cells were transfected with Orai1, Orai3 or concatenated channels (1-1-1-1, 3-1-1-1, 3-1-3-1,
3-1-1-3, 3-1-3-3) and store-depletion was prevented by omitting IP3 and clamping intracellular Ca2+ to
200 nM (Figure 3).
Using this experimental set up, 50 µM 2-APB induced a small outward current in cells expressing
Orai1 (Figure 3A), while cells expressing Orai3 developed a large outward current (Figure 3B) in
line with previously published results [60]. IVs at the indicated time points are displayed as insets
(Figure 3A,B). We next assessed 2-APB-induced currents from cells expressing concatenated channels,
when store depletion was omitted (Figure 3C). All IVs are displayed in Figure 3D and quantification
of CDs is given in Figure 3E. 2-ABP induced no currents in cells expressing concatenated channels
containing no or one Orai3 subunit. 2-APB-induced outward currents were observed when two or
more Orai3 subunits were present in the channel and an increasing number of Orai3 channels led to
increased outward currents. The order of Orai3 subunits within the concatenated channel apparently
determines the size of the outward current as the current size is larger in 3-1-3-1 compared to 3-1-1-3.
We next transfected HEK 293 WT cells with 1-1-1-1, 3-1-1-1, 3-1-3-1, 3-1-1-3, 3-1-3-3 concatented
channels or control and applied 50 µM 2-APB when intracellular Ca2+ was clamped to 200 nM
(Figure 4A–C, IVs are shown in Figure 4B) or stores were depleted with IP3 and Ca2+ was clamped to
near zero with 20 mM BAPTA (Figure 4D–F, IVs are shown in Figure 4E).
Similar to the experiments with HEK293 STIM1 cells (Figure 3C–E) the data in Figure 4 demonstrate
that two or more Orai3 subunits in the concatenated channel are sufficient to mediate a 2-APB-induced
outward current, when endogenous STIM1 is not recruited to the plasma membrane (Figure 4A–C) or
may assemble with the channel (Figure 4D–F).
Int. J. Mol. Sci. 2020, 21, 2458 6 of 13
 5 of 13 
 
 
Figure 2. Current density responses in HEK cells stably overexpressing STIM1 with overexpression 
of concatenated tetrameric Orai1/Orai3 channels or empty vector control under store-depleting 
conditions. (A) CD development over time and application of 50 µM 2-APB as indicated (1-1-1-1, n = 
6; 3-1-1-1, n = 12; 3-1-1-3, n = 10; 3-1-3-1, n = 7; 3-1-3-3, n = 10; control, n = 7). (B) Inward currents at t = 
116 s extracted from (A). (C) Outward currents extracted at t = 178 s extracted from (A). (D) 
Corresponding IV relationships from (A). Statistical significance was determined by an unpaired t 
test with Welch’s correction and is presented as ns p > 0.05, * p < 0.05, ** p < 0.005, *** p < 0.001, **** p < 
0.0001. 
2.2. Non-Store-Operated Orai1, Orai3 and Concatenated Orai1/Orai3 Channels 
We next investigated the pharmacological profile upon application of 50 µM 2-APB when HEK 
STIM1 cells were transfected with Orai1, Orai3 or concatenated channels (1-1-1-1, 3-1-1-1, 3-1-3-1, 3-
1-1-3, 3-1-3-3) and store-depletion was prevented by omitting IP3 and clamping intracellular Ca2+ to 
200 nM (Figure 3). 
 
Figure 3. 2-APB-mediated current density responses in HEK cells stably overexpressing STIM1 with 
internal Ca2+ clamped to 200 nM and no store depletion. (A) CD development over time with Orai1 
overexpression (n = 9) and application of 50 µM 2-APB as indicated. Corresponding IV relationship 
in inset on the upper left. (B) Same experimental setting as in (A) but with Orai3 overexpression (n = 
8). (C) Same experimental setting as in (A) but with overexpression of concatenated tetrameric 
Orai1/Orai3 channels or empty vector as a control (1-1-1-1, n = 7; 3-1-1-1, n = 5; 3-1-1-3, n = 9; 3-1-3-1, 
n = 8; 3-1-3-3, n = 5; control, n = 6). (D) Corresponding IV relationships extracted from cells in (C). (E) 
Analysis of 2-APB-mediated outward currents from (C) at t = 178 s. Statistical significance was 
determined by an unpaired t test with Welch’s correction and is indicated as ns p > 0.05, * p < 0.05, ** 
p < 0.005, *** p < 0.001. 
Using this experimental set up, 50 µM 2-APB induced a small outward current in cells expressing 
Orai1 (Figure 3A), while cells expressing Orai3 developed a large outward current (Figure 3B) in line 
with previously published results [60]. IVs at the indicated time points are displayed as insets (Figure 
Figure 3. 2-APB-mediated current density respons in HEK cells stably overexpressing STIM1 with
internal Ca2+ clamped to 200 nM and no store depletion. (A) CD development over time with Orai1
overexpression (n = 9) and application of 50 µM 2-APB as indicated. Corresponding IV relationship in
inset on the upper left. (B) Sa experimental setting as in (A) but with Or i3 overexpression (n = 8).
(C) Same experimental setting as in (A) but with overexpression of concatenated tetrameric Orai1/Orai3
channels or empty vector as a control (1-1-1-1, n = 7; 3-1-1-1, n = 5; 3-1-1-3, n = 9; 3-1-3-1, n = 8; 3-1-3-3,
n = 5; control, n = 6). (D) Corresponding IV relationships extracted from cells in (C). (E) Analysis of
2-APB-mediated outward currents from (C) at t = 178 s. Statistical significance was determined by an
unpaired t test with Welch’s correction and is indicated as ns p > 0.05, * p < 0.05, ** p < 0.005, *** p < 0.001.
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Similar to the experiments with HEK293 STIM1 cells (Figure 3C–E) the data in Figure 4 
demonstrate that two or more Orai3 subunits in the concatenated channel are sufficient to mediate a 
2-APB-induced outward current, when endogenous STIM1 is not recruited to the plasma membrane 
(Figure 4A–C) or may assemble with the channel (Figure 4D–F). 
2.3. Comparison to Prostate Cancer Cells 
Figure 4. 2-APB-mediated current density responses in HEK 293 WT cells. (A) CD development
after overexpr ssion of concaten d etrameric O i1/Orai3 channels or empty vector as a control
when internal Ca2+ is clamped to 200 nM (1-1-1-1, n = 9; 3-1-1-1, n = 7; 3-1-1-3, n = 5; 3-1-3-1, n = 8;
3-1-3-3, n = 9; e pty vector, n = 7). Application of 50 µM 2-APB as indicated. (B) Corresponding IV
relationships from cells in (A). (C) Analysis of 2-APB-mediated outward currents from (A) at t = 178 s.
(D) same experimental setting as in (A) but with 50 µM IP3 and 0 nM Ca2+ in the patch pipette (1-1-1-1,
n = 9; 3-1-1-1, n = 13; 3-1-1-3, n = 6; 3-1-3-1, n = 11; 3-1-3-3, n = 8; control, n = 11). (E) Corresponding IV
relationships from cells in (D). (F) Analysis of 2-APB-mediated outward currents from (D) at t = 178 s.
Statistical significance was determined by an unpaired t test with Welch’s correction and is indicated as
ns p > 0.05, * p < 0.05, ** p < 0.005, **** p < 0.0001.
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2.3. Comparison to Prostate Cancer Cells
In many cell types, e.g., T cells, B cells and mast cells, ICRAC is first amplified and then completely
blocked when 50 µM 2-APB is applied [41–43].
We have previously shown that in the prostate cancer cell line LNCaP a low number of Orai3
subunits within store-operated CRAC channels alters the 2-APB response compared to Orai1-mediated
currents when 50 µM was applied [18].
To compare data from LNCaP prostate cancer cells with concatenated channels, we normalized
data from Figure 2 and data from LNCaP when 50 µM 2-APB were applied. Data were normalized to
CD at 116 s when ICRAC had fully developed (Figure 5A). A bar diagram of the 2-APB-induced block
is shown in Figure 5B. We here omit all outward currents as outward current development was not
observed in endogenous cells.
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stably overexpressing STIM1 with overexpression of concatenated tetrameric Orai1/Orai3 channels,
and LNCaP prostate cancer cells. (A) CD development when 50 µM 2-APB was applied as indicate .
Traces were normalized to the CD at t = 116 s after subtraction of leak currents (1-1-1-1, n = 4; 3-1-1-1,
n = 5; 3-1-1-3, n = 5; 3-1-3-1, n = 6; 3-1-3-3, n = 5, LNCaP n = 14). (B) Percentage of 2-APB-mediated CD
i hibition at t = 178 s extracted from (A). (C) CD development in concaten ted constructs 1-1-1-1 and
3-1-1-1 (n = 7 and n = 9) when 25 µM 2-APB was applied as indicated. Traces were normalized to the
CD at t = 116 s after leak subtraction. (D) Percentage of 2-APB-m iated CD inhibition at t = 178 s
extracted from (C). Statistical significance in (D) w s determined by an unpaired t test with Welch’
correction and is indicated as ns p > 0.05.
None of the concatenated channels displayed the exact pharmacological profile of LNCaP cells.
However, ICRAC from cells expressing concatenated channels exhibit a similar pharmacological profile
as the prostate cancer cells. It is possible that the concatenation of subunits changes the complex
pharmacological profile. Moreover, endogenous CRAC channels might exist as a mixed population of
channels composed of varying numbers of Orai1/Orai3 subunits that cannot be simulated with one
distinct channel composition.
Concatenated channels 1-1-1-1 and 3-1-1-1 gave similar results upon application of 50 µM 2-APB.
Strikingly, one Orai3 subunit in 3-1-1-1 seemed to reduce the 2-APB-induced block compared to 1-1-1-1.
We further evaluated this question by applying 25 µM 2-APB in a second experiment (Figure 5C,D).
Under these conditions, we still detected the amplification of ICRAC followed by a block. Adding one
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Orai3 subunit to the channel does not alter 2-APB pharmacological profile. Please note that under
these conditions the 2-APB-induced block ([2-APB] = 30 µM) is absent in LNCaP cells [18].
Taken together, none of the concatenated channels displayed the exact pharmacological profile of
LNCaP cells; however, here, we speculate that endogenous store-operated Orai1/Orai3 channels are
formed with one or more Orai3 subunit(s).
3. Discussion
The versatile role of SOCE channels in physiology/pathophysiology make them an attractive
therapeutic target. Endogenous heteromeric store-operated Orai/Orai3 channels exhibit a complex but
promising pharmacology [16,18,25,27,28,40,59], however, their investigation is challenging. In this work
we used concatenated channels with defined Orai1 and Orai3 subunit stoichiometry and arrangement
to systematically investigate their complex pharmacology using a widely used tool compound (2-APB).
Upon activation by STIM1, all channels exhibited the typical inwardly rectified ICRAC. When store
depletion was prevented or only endogenous STIM1 was present at the channel, no ICRAC was observed.
In line with previous studies [15,61], the expression of one or more Orai3 subunit(s) within these channels
result in a significant reduction of ICRAC that was also observed in endogenous systems [15–18,23,24].
In concatenated channels, expression of two or more Orai3 subunits resulted in 2-APB-induced outward
currents in STIM1-dependent and store-independent 2-APB-activated channels. The amount of this
outward current gradually increased with the number of Orai3 subunits (3-1-3-1 < 3-1-1-3 < 3-1-3-3).
From experiments with channel constructs containing two Orai3 subunits, we can conclude that
the pore size depends on the position of Orai1 and Orai3 subunits within the multimeric channel
arrangement. To our knowledge, such outward currents were never observed in endogenous cells.
Strikingly, presence of STIM1 at the channels increased 2-APB-induced outward component by 2-fold.
This has been observed earlier [50] and may indicate that STIM1 is present at the 2-APB-activated
channel and adds to ion channel conductivity. In contrast, it has been published that STIM1 dissociates
from the channel before 2-APB-induced conductivity is observed [57]. One explanation might be
that STIM1 activation before 2-APB application results in 2-APB-activated channels that differ from
2-APB-activated channels that originate from a closed (STIM1 free) state. In addition to STIM1/Orai1
and STIM1/Orai3, STIM2/Orai1 and STIM2/Orai3 can form store-operated channels. Without store
depletion, STIM2/Orai1 overexpressing HEK293 cells give a transient current response upon application
of 50 µM 2-APB that is absent in STIM1/Orai1-expressing cells [62]. Future studies may compare the
2-APB response from STIM2 and Orai1, Orai3, or concatenated channel overexpression systems to
functionally analyze the pharmacology of STIM2-expressing endogenous cells.
The response of prostate cancer cells LNCaP to the application of 50 µM 2-APB could not be
exactly simulated with any concatenated channel. Concatenated channels may differ in their response
to 2-APB as subunits are linked by an additional intramolecular connection. In addition, endogenous
channels may form mixed heteromeric populations in contrast to concatenated channels that represent
one defined subunit composition. Furthermore, we cannot exclude that an additional 2-APB-sensitive
component adds to heteromeric SOCE channels altering the Orai1/Orai3-mediated response such as
TRPC [63,64].
The ROS-dependent block is abolished when one Orai3 subunit is present within the channel [15].
In contrast, no difference in current is observed between 1-1-1-1 and 3-1-1-1 in response to 2-APB.
In conclusion, endogenous heteromeric Orai1/Orai3 channels with only one Orai3 subunit may be
undistinguishable from homomeric Orai1 channels in their 2-APB profile. Development of tool
compounds based on the known 2-APB or other scaffolds that distinguish homomeric Orai1 channels
and heteromeric channels with one Orai3 subunit may help to identify heteromeric Orai channels in
various endogenous cell types in the future. Blocking or activating distinct heteromeric store-operated
channels may be the key for specific modulations of SOCE in cancer and immune therapy.
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4. Materials and Methods
4.1. Cell Culture and Transfection
All cells were cultivated at 37 ◦C and 5% CO2. MEM medium (Gibco, Thermo Fisher Scientific,
Waltham, MA, USA) supplemented with 10% FCS (Gibco) was used for HEK 293 WT cells. HEK
293 cells stably expressing STIM1 were grown in MEM medium supplemented with 10% FCS and
500 µg/mL G418 (Gibco). All cells were transfected with 1 µg DNA per 106 cells in a Nucleofector
4D device with Nucleofector Kit SF (Lonza, Basel, Switzerland), according to the manufacturer’s
guidelines. DNA constructs 1-1-1-1, 3-1-1-1, 3-1-3-1 and 3-1-3-3 were generated previously [33,65]. All
work was performed under the ethics approval of the Bundesamt für Umwelt, Switzerland to the
Institute of Biochemistry and Molecular Medicine (A141370).
4.2. Electrophysiology
All patch-clamp experiments were performed in a whole-cell setting at 20-24 ◦C. Currents were
acquired and filtered at 2.9 kHz with a HEKA EPC-10 amplifier (HEKA Elektronik, Lambrecht (Pfalz),
Germany) and recorded with the HEKA Patchmaster (v2×53) software. Every 2 s, 50 ms voltage ramps
spanning −150 mV to 150 mV from a holding potential of 0 mV were applied. All currents were
corrected for a liquid junction potential of 10 mV. Capacitive currents were corrected before every
voltage ramp delivery. For analysis, currents at −130 mV and 130 mV were extracted, normalized to
cell capacitance, and plotted versus time. The error bars represent the standard error of the mean
(SEM) if not indicated otherwise. Any additional normalizations, if used, are mentioned in the figure
captions. Data was analyzed with Igor Pro 6.37 (Wavemetrics, Lake Oswego, OR, USA). Bath solution
contained: 120 mM NaCl, 20 mM CaCl2, 10 mM TEA-Cl, 10 mM HEPES, 2 mM MgCl2. Store-depleting
pipette solution contained: 120 mM Cs-glutamate, 20 mM BAPTA (10 mM for LNCaP), 10 mM HEPES,
3 mM MgCl2, 50 µM IP3. In pipette solution that prevented store depletion, IP3 was omitted and
calcium was clamped to 200 nM with BAPTA. Calcium concentration was calculated according to
WEBMAXC STANDARD [66]. Osmolarity was adjusted with glucose to 310 mOsm. Under these
conditions, pipettes had resistances of 2–3 MΩ.
4.3. Statistical Analysis
Statistical tests were performed in GraphPad Prism 8 (GraphPad Software, San Diego, CA, USA)
as detailed in the figure captions.
5. Conclusions
Targeting endogenous heteromeric ion channels in therapeutic interventions is generally very
challenging. Often their pharmacological behavior varies with subunit composition and arrangement.
Here, we used concatenated SOCE channels in order to rationalize the action of 2-APB on different
Orai1/Orai3 channel architectures. Our findings show that as Orai3 content is increased, in particular, 2-APB
pharmacology digresses significantly from mostly Orai1 containing channels. Ultimately, our long-term
goal is to generate SOCE channel subtype-dependent pharmacology profiles that can be exploited
therapeutically in diseased native cells.
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Abbreviations
IP3 inositol 1,4,5-trisphosphate
SOCE store-operated Ca2+ entry
ICRAC Ca2+ release activated Ca2+ current
Ca2+ calcium ions
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